Piermont Capital Management’s Select Medical SEM Stock Holding History

Piermont Capital Management’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-40,368	Closed	-$395K	–	194
2018 Q2	$395K	Sell	40,368 -7,584	-16%	-$74.5K	0.12%	180
2018 Q1	$446K	Sell	47,952 -7,386	-13%	-$70.3K	0.15%	172
2017 Q4	$526K	Sell	55,338 -3,163	-5%	-$30.2K	0.17%	150
2017 Q3	$605K	Sell	58,501 -59,910	-51%	-$553K	0.2%	135
2017 Q2	$979K	Sell	118,411 -20,267	-15%	-$152K	0.28%	142
2017 Q1	$997K	Buy	+138,678	New	+$1.01M	0.24%	156

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Piermont Capital Management's SEM Position: Q3 2018 in Review

Piermont Capital Management sold out of Select Medical (SEM) in Q3 2018, closing a stake of 40,368 shares — an estimated $395K sold.

Piermont Capital Management first reported a position in SEM in Q1 2017 and held it in 6 quarters. The position peaked at $997K in Q1 2017. 197 funds tracked by Wall St. Rank hold SEM as of Q3 2018.

Piermont Capital Management reported no remaining Select Medical position as of Q3 2018 after selling out during the quarter.
Piermont Capital Management sold 40,368 Select Medical shares in Q3 2018, an estimated $395K.
Piermont Capital Management first reported a position in Select Medical in Q1 2017 and held it in 6 quarters.
Piermont Capital Management's Select Medical position peaked at $997K in Q1 2017.
197 funds tracked by Wall St. Rank held Select Medical as of Q3 2018.

Based on Piermont Capital Management's 13F filing for Q3 2018, filed 6 Nov 2018.